China National Accord Medicines Corp Ltd (200028) — Financial Flexibility Index
China National Accord Medicines Corp Ltd (200028) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of HK$-364.00 Million (operating CF HK$-424.00 Million minus capex HK$60.00 Million) represents 0% of total liabilities (HK$29.01 Billion). Check 200028 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China National Accord Medicines Corp Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for China National Accord Medicines Corp Ltd across 28 annual periods. See China National Accord Medicines Corp Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for China National Accord Medicines Corp Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for China National Accord Medicines Corp Ltd. For the full company profile including market capitalisation, see China National Accord Medicines Corp Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (HKD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | HK$1.86 Billion | HK$1.64 Billion | HK$27.47 Billion | ▼ -49.1% |
| 2024 | 0.13x | HK$3.55 Billion | HK$3.27 Billion | HK$26.80 Billion | ▲ +8.2% |
| 2023 | 0.12x | HK$3.26 Billion | HK$2.94 Billion | HK$26.59 Billion | ▼ -1.5% |
| 2022 | 0.12x | HK$2.88 Billion | HK$2.56 Billion | HK$23.17 Billion | ▲ +52.1% |
| 2021 | 0.08x | HK$2.03 Billion | HK$1.66 Billion | HK$24.76 Billion | ▲ +3.4% |
| 2020 | 0.08x | HK$1.80 Billion | HK$1.50 Billion | HK$22.71 Billion | ▼ -36.0% |
| 2019 | 0.12x | HK$2.25 Billion | HK$2.00 Billion | HK$18.16 Billion | ▲ +17.7% |
| 2018 | 0.11x | HK$1.58 Billion | HK$1.32 Billion | HK$15.02 Billion | ▼ -12.5% |
| 2017 | 0.12x | HK$1.49 Billion | HK$1.29 Billion | HK$12.42 Billion | ▼ -14.4% |
| 2016 | 0.14x | HK$1.74 Billion | HK$1.47 Billion | HK$12.40 Billion | ▼ -13.4% |
| 2015 | 0.16x | HK$1.24 Billion | HK$1.05 Billion | HK$7.65 Billion | ▲ +384.4% |
| 2014 | -0.06x | HK$-454.03 Million | HK$-796.70 Million | HK$7.98 Billion | ▼ -180.8% |
| 2013 | 0.07x | HK$615.52 Million | HK$465.03 Million | HK$8.74 Billion | ▲ +1.5% |
| 2012 | 0.07x | HK$517.53 Million | HK$323.96 Million | HK$7.46 Billion | ▲ +1.6% |
| 2011 | 0.07x | HK$426.29 Million | HK$227.32 Million | HK$6.24 Billion | ▼ -41.7% |
| 2010 | 0.12x | HK$606.15 Million | HK$428.16 Million | HK$5.18 Billion | ▲ +36.5% |
| 2009 | 0.09x | HK$373.78 Million | HK$270.85 Million | HK$4.36 Billion | ▼ -21.5% |
| 2008 | 0.11x | HK$331.56 Million | HK$246.58 Million | HK$3.03 Billion | ▲ +64.0% |
| 2007 | 0.07x | HK$159.11 Million | HK$87.70 Million | HK$2.39 Billion | ▼ -51.0% |
| 2006 | 0.14x | HK$299.95 Million | HK$181.73 Million | HK$2.21 Billion | ▼ -53.6% |
| 2005 | 0.29x | HK$198.90 Million | HK$148.28 Million | HK$678.73 Million | ▼ -1.0% |
| 2004 | 0.30x | HK$144.48 Million | HK$130.30 Million | HK$487.99 Million | ▲ +50.9% |
| 2003 | 0.20x | HK$130.58 Million | HK$81.22 Million | HK$665.47 Million | ▲ +153.1% |
| 2002 | 0.08x | HK$55.66 Million | HK$28.76 Million | HK$717.90 Million | ▼ -45.4% |
| 2001 | 0.14x | HK$107.06 Million | HK$71.16 Million | HK$753.72 Million | ▼ -58.7% |
| 2000 | 0.34x | HK$29.53 Million | HK$8.52 Million | HK$85.83 Million | ▼ -40.8% |
| 1999 | 0.58x | HK$50.38 Million | HK$22.84 Million | HK$86.72 Million | ▲ +325.2% |
| 1998 | 0.14x | HK$15.59 Million | HK$5.21 Million | HK$114.11 Million | — |